CuraMedix is committed to helping medical professionals integrate a range of innovative, evidence-based, non-surgical tools and technology to include Extracorporeal Magnetotransduction Technology (EMTT) into their continuum of care. This enables them to broaden their treatment options and help patients get better faster without surgery, risk, or downtime.
As one of the newest and most innovative technologies to treat chronic musculoskeletal diseases, EMTT is evidence-based, non-invasive, and an exceptional complement to EPAT/ESWT. Compared to other magnetic field technology, EMTT distinguishes itself due to its high oscillation frequency of 100 – 300 kHz. This feature allows for deeper penetration and a more comprehensive range of applications.
CuraMedix is thrilled to announce the launch of the new EMTT (Extracorporeal Magnetotransduction Technology) device, the MAGNETOLITH, powered by STORZ Medical.
Initially, the first in the U.S. to hear of EMTT attended a conference last fall sponsored by The Institute for Tissue Generation and Repair. Share in the excitement by watching this compelling webinar "The Official U.S. Introduction to EMTT and the MAGNETOLITH Debut" featuring Dr. Ludger Gerdesmeyer.
Primary Indications for the Use of EMTT
EMTT can be used to treat numerous musculoskeletal disorders and a variety of pain syndromes. This technology is backed by significant research, and has shown to be extremely successful in the regeneration and rehabilitation of complicated conditions. Look with confidence to Extracorporeal Magnetotransduction Technology to treat the dysfunctions listed below:
- Degenerative joint disorders
- Wear and tear conditions such as osteoarthritis (knees, hips, hands, shoulders, elbows), herniated discs, spondylarthrosis
- Pain treatment - Chronic pain, for example, back pain, lumbago, tension, radiculopathy
- Sports injuries - Chronic inflammation of tendons and joints, tendon overuse syndromes, inflammation of the pubic bone
- Relaxation of muscle spasms
- Prevention or retardation of disuse atrophy to temporarily increase local blood circulation in healthy leg muscles
- Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis
- Maintaining or improving range of motion
- Temporary relief of pain associated with sore and aching muscles in the:
– Upper extremities
– Lower extremities
9 Noteworthy Benefits of Using EMTT
With the introduction of EMTT, a new magnetic field technology, medical professionals will be able to offer patients a superior tissue-healing technology that provides a more comfortable and streamlined experience. Patients will find that treatment with the MAGNETOLITH system is painless for the patient and easy for the medical professional to administer. The clear advantages of using EMTT include the following:
- Wide range of applications
- Outpatient procedure
- No need to remove clothing
- No side effects
- Easy to use
- High level of patient comfort
- An excellent complement to EPAT/ESWT
Spotlight on Facts, Figures, and MAGNETOLITH Parameters
Please note that while EMTT relies on a different operating mechanism than ESWT does, the two modalities are highly effective when used together. Consider the value of these two exceptional treatments: EPAT/ESWT acts using high-energy acoustic/physical signals in a local treatment area, while EMTT acts using high-energy electromagnetic radiation in a regional treatment area.
Here are the highlights on EMTT:
- High oscillating frequency with high penetration depth (100 – 300 kHz)
- The device offers continuous and reliable operation by a water-cooled applicator
- Simple plug in and plug out to change the applicator
- Integrated touch display to adjust energy level, frequency, and pulse rate
- Flexible holding arm and one locking knob for easy positioning
- Effectivity and safety are proven in studies
|Oscillation frequency||130 kHz|
|Oscillations per pulse||>15|
|Maximum field strength (at the coil)||0.6 T|
|Magnetic field strength (4cm distance from the coil)||60 mT|
|Performance of the magnetic field (dB max/dt)||65.300 T/s|
4 Studies That Highlight the Significant Effects of This Magnetic Field Technology
There is tremendous value in clinical data when it comes to new technology. EMTT is a revolutionary magnetic field technology backed by science. The articles and evidence listed below offer insight into the significant therapeutic effects of using EMTT devices.
Some of the information contained in the articles listed may pertain to products, indications for use of products and/or treatments/ procedures that are only available outside the United States and have not been approved or cleared for marketing by the United States Food & Drug Administration.
Electromagnetic Transduction Therapy And Shockwave Therapy in 86 Patients With Rotator Cuff Tendinopathy: A Prospective Randomized Controlled Trial appeared in Electromagnetic Biology and Medicine (2018)
Electromagnetic Transduction Therapy in Non-Specific Low Back Pain: A Prospective Randomised Controlled Trial published in Journal of Orthopaedics (2017)
Electromagnetic Transduction Therapy for Achilles Tendinopathy: A Preliminary Report on a New Technology in The Journal for Foot and Ankle Surgery (2017)
Electromagnetic Transduction Therapy in Patients with Chronic Aseptic Osteitis Pubis inside the Journal of Orthopedic Research and Therapy 2018
Be Among the First to Add EMTT to Your Continuum of Care
As a medical professional, it's vital to have the latest medical technology to provide best in class care to your patients. Here's what one world-renowned physician says about this latest breakthrough technology.
"The MAGNETOLITH, using high-end, non-invasive EMTT technology, is a potent tissue healing stimulator on various musculoskeletal tissue to include bones, tendons, muscles, joints, and fascia. In combination with focused shock wave and radial pressure wave, evidence-based EMTT appears to be a highly effective partner lifting my tissue healing expectations to another level; and this, after over 500 treatments using the MAGNETOLITH, without any apparent risk in the young, the older, and the advanced athletes.”
— Dr. Karsten Knobloch, MD
Interested in learning more and discussing this unique opportunity? Contact us to continue the conversation. Or view the EMTT webinar presented by Dr. Ludger Gerdesmeyer to learn more.